Two specific major targets include the upregulation of miR-101b and miR-455, which in turn led to decreased levels of IL-6 and TNF-α; these are pro-inflammatory proteins known to be promoters of colon cancer [41,42]. The gene discussed is IL6; the disease is malignant colon neoplasm.